Abemaciclib

Categorie:

Beschrijving

Titel: Adding abemaciclib to fulvestrant delays disease progression and prolongs the survival of women with HR+/HER2 negative advanced breast cancer across treatment lines, with a particularly pronounced survival benefit in patients with poor prognostic features

Gepubliceerd: BJMO 2020, September

Copyright: 2020 © Ariez BV

Translate »